Progress was made on 114 substances. Evaluation was completed for 22 substances resulting in 16 draft decisions and 6 conclusions. Another 11 draft decisions were sent as a result of follow-up evaluation and 15 substance evaluations, from previous evaluation years, were concluded. Of the 21 substance evaluation conclusions published in 2018, 6 concluded that the risks are sufficiently controlled with existing measures, and 15 concluded that further risk management measures are necessary.
